Vazegepant hydrochloride
Product Specifications
CAS Number
1414976-20-7
Target
CGRP Receptor
Related Pathways
Neuroscience, GPCR/G Protein
Purity
0.9956
Bioactivity
Vazegepant hydrochloride (Vazegepant HCl) is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
Smiles
Cl.CN1CCC(CC1)N1CCN(CC1)C(=O)[C@@H](Cc1cc(C)c2[nH]ncc2c1)NC(=O)N1CCC(CC1)c1cc2ccccc2[nH]c1=O
Molecular Formula
C36H47ClN8O3
Molecular Weight
675.3
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB2318-100 1x 100 µL
ERCC1 / RAD10 (Tumor Progression Marker) (ERCC1/2318), 0.2mg/mL
Sign In for Pricing
View Details 
BNC041149-100 1x 100 µL
CD71 (TFRC/1149), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
